Retrospective Study
Copyright ©The Author(s) 2016.
World J Gastroenterol. Nov 21, 2016; 22(43): 9586-9594
Published online Nov 21, 2016. doi: 10.3748/wjg.v22.i43.9586
Table 1 Demographic, biological, and histological features for the training and validation groups
VariableAll (n = 193)Training group (n = 97)Validation group (n = 96)P value
Age, in yr39.11 ± 9.3138.70 ± 9.4639.52 ± 9.180.542
Sex, n (%)0.601
Male138 (71.5)71 (73.2)67 (69.8)
Female55 (28.5)26 (26.8)29 (30.2)
Total bilirubin, in μmol/L12.3 (8.7-18.2)11.4 (8.6-16.9)12.9 (8.8-18.8)0.352
Albumin, in g/L42.21 ± 4.1642.46 ± 3.9141.94 ± 4.410.387
Globulin, in g/L27.25 ± 4.3627.54 ± 4.8426.95 ± 3.810.345
ALT, in IU/L37 (27-51)35 (26.0-48.5)38.5 (28-52)0.378
AST, in IU/L30 (25.0-37.5)30 (26-38)29 (25-37)0.806
GGT, in IU/L27 (18.0-40.5)25 (18-38)27 (19-43)0.577
TBA, in mmol/L5.9 (3.85-12.05)6.5 (4.10-15.25)5.45 (3.73-9.83)0.146
ALP, in IU/L69 (57.5-82.5)69 (58.0-83.5)68.5 (57.0-81.8)0.990
CHE, in IU/L8407.62 ± 2722.198393.56 ± 2423.518421.83 ± 3006.820.943
AFP, in ng/mL3.25 (2.19-6.32)3.30 (2.30-6.70)3.20 (2.03-5.08)0.377
PT, in s12.4 (11.9-13.1)12.4 (11.95-13.15)12.3 (11.80-12.97)0.061
INR1.03 (0.98-1.09)1.03 (0.99-1.10)1.03 (0.98-1.08)0.553
HBsAg levels, in log IU/mL3.49 (3.12-3.97)3.46 (3.08-3.90)3.52 (3.16-4.03)0.501
HBV DNA levels, in logIU/mL5.27 ± 1.705.30 ± 1.675.24 ± 1.740.791
WBC, in 109/L5.63 ± 1.495.66 ± 1.545.59 ± 1.440.723
PLT, in 109/L179 (144.5-214.5)179 (153.5-214.5)177 (128.0-214.8)0.208
CP, in mg/L195.67 ± 35.62196.86 ± 35.45196.86 ± 35.450.643
Stage of fibrosis, n (%)0.164
F176 (39.38)42 (43.30)34 (35.42)
F244 (22.80)23 (23.71)21 (21.88)
F342 (21.76)18 (18.56)24 (25.00)
F431 (16.06)14 (14.43)17 (17.70)